Also known as: Dorian therapeutics
New therapeutics to rejuvenate tissue and treat age-related diseases
Company was acquired
Event Year: 2018
Company was acquired
Event Year: 2018
Dorian Therapeutics was focused on developing innovative therapeutic solutions aimed at rejuvenating tissue and addressing the underlying causes of age-related diseases. Their research and development efforts were geared towards creating novel treatments that could potentially improve the health and well-being of individuals affected by the aging process. The company sought to translate scientific discoveries into tangible medical advancements in the healthcare sector, ultimately contributing to a longer and healthier lifespan for patients.
Dorian Therapeutics was focused on developing innovative therapeutic solutions aimed at rejuvenating tissue and addressing the underlying causes of age-related diseases. Their research and development efforts were geared towards creating novel treatments that could potentially improve the health and well-being of individuals affected by the aging process. The company sought to translate scientific discoveries into tangible medical advancements in the healthcare sector, ultimately contributing to a longer and healthier lifespan for patients.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2018
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2018
Healthcare
Healthcare
Healthcare -> Therapeutics
Healthcare -> Therapeutics
Team size: 8
Hiring: No
Team size: 8
Hiring: No
